Display options
Cite
Miquel S, Lagrafeuille R, Souweine B, et al. Anti-biofilm Activity as a Health Issue. Front Microbiol. 2016;7:592doi: 10.3389/fmicb.2016.00592.
Miquel, S., Lagrafeuille, R., Souweine, B., & Forestier, C. (2016). Anti-biofilm Activity as a Health Issue. Frontiers in microbiology, 7592. https://doi.org/10.3389/fmicb.2016.00592
Miquel, Sylvie, et al. "Anti-biofilm Activity as a Health Issue." Frontiers in microbiology vol. 7 (2016): 592. doi: https://doi.org/10.3389/fmicb.2016.00592
Miquel S, Lagrafeuille R, Souweine B, Forestier C. Anti-biofilm Activity as a Health Issue. Front Microbiol. 2016 Apr 26;7:592. doi: 10.3389/fmicb.2016.00592. eCollection 2016. PMID: 27199924; PMCID: PMC4845594.
Copy Download .nbib Format: NLM
Share it on

Front Microbiol. 2016 Apr 26;7:592. doi: 10.3389/fmicb.2016.00592. eCollection 2016.

Anti-biofilm Activity as a Health Issue.

Frontiers in microbiology

Sylvie Miquel, Rosyne Lagrafeuille, Bertrand Souweine, Christiane Forestier

Affiliations

  1. Laboratoire Microorganismes : Génome et Environnement - UMR, CNRS 6023, Université Clermont Auvergne Clermont-Ferrand, France.
  2. Laboratoire Microorganismes : Génome et Environnement - UMR, CNRS 6023, Université Clermont AuvergneClermont-Ferrand, France; Service de Réanimation Médicale Polyvalente, CHU de Clermont-Ferrand, Clermont-FerrandFrance.

PMID: 27199924 PMCID: PMC4845594 DOI: 10.3389/fmicb.2016.00592

Abstract

The formation and persistence of surface-attached microbial communities, known as biofilms, are responsible for 75% of human microbial infections (National Institutes of Health). Biofilm lifestyle confers several advantages to the pathogens, notably during the colonization process of medical devices and/or patients' organs. In addition, sessile bacteria have a high tolerance to exogenous stress including anti-infectious agents. Biofilms are highly competitive communities and some microorganisms exhibit anti-biofilm capacities such as bacterial growth inhibition, exclusion or competition, which enable them to acquire advantages and become dominant. The deciphering and control of anti-biofilm properties represent future challenges in human infection control. The aim of this review is to compare and discuss the mechanisms of natural bacterial anti-biofilm strategies/mechanisms recently identified in pathogenic, commensal and probiotic bacteria and the main synthetic strategies used in clinical practice, particularly for catheter-related infections.

Keywords: anti-biofilm; biofilm; lock solution; pathogens; probiotics

References

  1. J Bacteriol. 2009 Mar;191(5):1393-403 - PubMed
  2. Int J Antimicrob Agents. 2015 May;45(5):551-3 - PubMed
  3. Intensive Care Med. 2004 Oct;30(10):1891-9 - PubMed
  4. Am J Respir Crit Care Med. 2015 May 1;191(9):1024-32 - PubMed
  5. Intensive Care Med. 2008 Jun;34(6):1030-7 - PubMed
  6. J Hosp Infect. 2013 Oct;85(2):87-93 - PubMed
  7. Am J Infect Control. 2016 Jan 1;44(1):50-3 - PubMed
  8. J Antimicrob Chemother. 2008 Oct;62(4):809-15 - PubMed
  9. Int J Nanomedicine. 2015 May 06;10 :3367-75 - PubMed
  10. Pediatr Blood Cancer. 2013 Aug;60(8):1292-8 - PubMed
  11. FEMS Immunol Med Microbiol. 2011 Nov;63(2):236-47 - PubMed
  12. Res Pharm Sci. 2013 Oct;8(4):260-8 - PubMed
  13. Int J Artif Organs. 2009 Sep;32(9):545-54 - PubMed
  14. J Contemp Dent Pract. 2015 Apr 01;16(4):291-8 - PubMed
  15. Anaerobe. 2015 Aug;34:132-8 - PubMed
  16. PLoS One. 2010 May 26;5(5):e10840 - PubMed
  17. Crit Care Med. 2009 Feb;37(2):702-12 - PubMed
  18. Microbiol Spectr. 2015 Jun;3(3):null - PubMed
  19. PLoS One. 2014 Jul 07;9(7):e101677 - PubMed
  20. Methods Mol Biol. 2014;1147:175-86 - PubMed
  21. Pathogens. 2014 Sep 18;3(3):759-68 - PubMed
  22. Antimicrob Agents Chemother. 2013 Nov;57(11):5717-20 - PubMed
  23. J Am Coll Surg. 2015 Sep;221(3):739-47 - PubMed
  24. Curr Microbiol. 2013 Nov;67(5):614-23 - PubMed
  25. Antimicrob Agents Chemother. 2014 Dec;58(12):7273-82 - PubMed
  26. World J Urol. 2014 Aug;32(4):1007-14 - PubMed
  27. Pharmacotherapy. 2002 Jan;22(1):105-8 - PubMed
  28. Blood Purif. 2014;37(3):179-87 - PubMed
  29. J Med Microbiol. 2015 Sep;64(9):1021-6 - PubMed
  30. J Antimicrob Chemother. 2012 Apr;67(4):944-50 - PubMed
  31. Nat Rev Gastroenterol Hepatol. 2014 Aug;11(8):506-14 - PubMed
  32. Lett Appl Microbiol. 2009 Aug;49(2):241-7 - PubMed
  33. Evid Based Complement Alternat Med. 2015;2015:246012 - PubMed
  34. Science. 1999 May 21;284(5418):1318-22 - PubMed
  35. PLoS Biol. 2010 Feb 23;8(2):e1000317 - PubMed
  36. Biotechnol Adv. 2015 Nov 1;33(6 Pt 2):1108-19 - PubMed
  37. Diagn Microbiol Infect Dis. 2011 May;70(1):112-8 - PubMed
  38. BMC Biol. 2013 May 21;11:61 - PubMed
  39. ISME J. 2014 Mar;8(3):564-74 - PubMed
  40. Appl Environ Microbiol. 2004 May;70(5):3024-40 - PubMed
  41. Am J Kidney Dis. 2015 Dec;66(6):1015-23 - PubMed
  42. Ann Surg. 2005 Aug;242(2):193-200 - PubMed
  43. Nephrol Dial Transplant. 2005 Jun;20(6):1238-40 - PubMed
  44. Nat Rev Drug Discov. 2010 Feb;9(2):117-28 - PubMed
  45. PLoS One. 2014 Jun 16;9(6):e99995 - PubMed
  46. Eur J Vasc Endovasc Surg. 2010 Dec;40(6):817-22 - PubMed
  47. Antimicrob Agents Chemother. 2005 Nov;49(11):4778-80 - PubMed
  48. Antimicrob Agents Chemother. 2014 Sep;58(9):5363-71 - PubMed
  49. Antimicrob Agents Chemother. 2009 Sep;53(9):3880-6 - PubMed
  50. PLoS One. 2015 Feb 17;10(2):e0117177 - PubMed
  51. Am J Kidney Dis. 2014 Mar;63(3):479-90 - PubMed
  52. PLoS One. 2016 Jan 22;11(1):e0147569 - PubMed
  53. Semin Respir Crit Care Med. 2011 Apr;32(2):139-50 - PubMed
  54. Appl Environ Microbiol. 2012 Aug;78(15):5119-26 - PubMed
  55. FEMS Microbiol Lett. 2005 Sep 15;250(2):237-43 - PubMed
  56. Appl Environ Microbiol. 1998 Jan;64(1):197-202 - PubMed
  57. Pathog Dis. 2014 Apr;70(3):432-9 - PubMed
  58. Cell Microbiol. 2009 Jul;11(7):1034-43 - PubMed
  59. PLoS One. 2013 May 14;8(5):e63844 - PubMed
  60. J Antimicrob Chemother. 2010 Sep;65(9):1955-8 - PubMed
  61. Appl Environ Microbiol. 2006 Mar;72(3):2005-13 - PubMed
  62. Microbiol Mol Biol Rev. 2014 Sep;78(3):510-43 - PubMed
  63. J Hosp Infect. 1999 Jul;42(3):219-29 - PubMed
  64. Int J Med Sci. 2013 Jul 20;10(9):1193-8 - PubMed
  65. Biotechnol Bioeng. 2008 May 1;100(1):1-18 - PubMed
  66. J Hosp Infect. 2006 Dec;64(4):313-25 - PubMed
  67. Mayo Clin Proc. 2006 Sep;81(9):1159-71 - PubMed
  68. Am J Physiol Gastrointest Liver Physiol. 2007 Jan;292(1):G315-22 - PubMed
  69. Antimicrob Agents Chemother. 2012 May;56(5):2314-25 - PubMed
  70. Clin Microbiol Rev. 2002 Apr;15(2):167-93 - PubMed
  71. Proc Natl Acad Sci U S A. 2006 Aug 15;103(33):12558-63 - PubMed
  72. Crit Care Med. 2007 Apr;35(4):1032-9 - PubMed
  73. Pharmaceuticals (Basel). 2015 Sep 09;8(3):559-89 - PubMed
  74. Benef Microbes. 2014 Sep;5(3):219-33 - PubMed
  75. Recent Pat DNA Gene Seq. 2013 Apr 1;7(1):66-73 - PubMed
  76. Biochem Biophys Res Commun. 2009 Feb 6;379(2):324-9 - PubMed
  77. Int J Oral Sci. 2014 Dec;6(4):189-94 - PubMed
  78. Mol Oral Microbiol. 2015 Feb;30(1):16-26 - PubMed
  79. Infect Control Hosp Epidemiol. 2002 Dec;23(12):748-56 - PubMed
  80. Clin Infect Dis. 2009 Jul 1;49(1):1-45 - PubMed
  81. J Antimicrob Chemother. 2003 Apr;51(4):849-55 - PubMed
  82. Curr Pharm Des. 2015;21(1):5-11 - PubMed
  83. Antimicrob Agents Chemother. 2013 Mar;57(3):1468-73 - PubMed
  84. Acta Pol Pharm. 2014 Jan-Feb;71(1):39-47 - PubMed
  85. J Agric Food Chem. 2015 Oct 14;63(40):8804-18 - PubMed
  86. Bacteriophage. 2013 Jan 1;3(1):e24219 - PubMed
  87. Antimicrob Agents Chemother. 2013 Nov;57(11):5572-9 - PubMed
  88. J Biomed Nanotechnol. 2014 Oct;10(10):2806-27 - PubMed
  89. Intensive Care Med. 1996 Oct;22(10):1066-9 - PubMed
  90. Clin Infect Dis. 2014 Dec 15;59(12):1741-9 - PubMed
  91. Crit Care Med. 1995 Jun;23(6):1033-9 - PubMed
  92. Photochem Photobiol Sci. 2004 May;3(5):436-50 - PubMed
  93. J Hosp Infect. 2010 Sep;76(1):1-11 - PubMed
  94. Infect Drug Resist. 2014 Dec 12;7:343-63 - PubMed
  95. Biofouling. 2013;29(4):443-55 - PubMed
  96. PLoS One. 2014 Mar 27;9(3):e91838 - PubMed
  97. Mol Immunol. 2009 May;46(8-9):1805-13 - PubMed
  98. J Biol Chem. 2007 Nov 16;282(46):33275-83 - PubMed
  99. PLoS Pathog. 2015 Feb 23;11(2):e1004653 - PubMed
  100. Clin J Am Soc Nephrol. 2010 Oct;5(10):1799-804 - PubMed
  101. Virulence. 2014 Apr 1;5(3):413-23 - PubMed
  102. Arch Intern Med. 2004 Apr 26;164(8):842-50 - PubMed
  103. Int J Mol Sci. 2015 Aug 28;16(9):20417-30 - PubMed
  104. Crit Care. 2009;13(4):R117 - PubMed
  105. Oral Dis. 2015 Jan;21(1):e128-34 - PubMed
  106. Clin Nutr. 2010 Aug;29(4):464-8 - PubMed
  107. Antimicrob Agents Chemother. 2009 Aug;53(8):3505-7 - PubMed
  108. J Immunol. 2011 Jun 1;186(11):6585-96 - PubMed
  109. Evid Based Complement Alternat Med. 2015;2015:879540 - PubMed
  110. FEMS Microbiol Rev. 2012 Sep;36(5):972-89 - PubMed
  111. MBio. 2012 Jul 31;3(4):e00198-12 - PubMed
  112. Dose Response. 2013 Jul 25;12(1):152-61 - PubMed
  113. J Hosp Infect. 2012 Apr;80(4):304-9 - PubMed
  114. Am J Infect Control. 2015 Jan;43(1):2-3 - PubMed
  115. J Bacteriol. 2013 Apr;195(8):1645-55 - PubMed
  116. Microbiology. 2010 Nov;156(Pt 11):3469-77 - PubMed
  117. Anaerobe. 2012 Oct;18(5):498-503 - PubMed
  118. Sci Rep. 2015 Aug 21;5:13412 - PubMed
  119. J Antimicrob Chemother. 2010 Oct;65(10):2164-71 - PubMed
  120. Vaccine. 2010 Apr 26;28(19):3496-505 - PubMed
  121. Microb Ecol. 2010 Oct;60(3):655-64 - PubMed
  122. J Appl Microbiol. 2007 May;102(5):1187-96 - PubMed
  123. Biointerphases. 2015 Jun 13;10(2):029404 - PubMed
  124. Anaerobe. 2012 Oct;18(5):508-15 - PubMed
  125. J Basic Microbiol. 2000;40(1):3-6 - PubMed
  126. Antimicrob Agents Chemother. 2012 May;56(5):2683-90 - PubMed
  127. J Antimicrob Chemother. 2014 Oct;69(10):2611-9 - PubMed
  128. Nat Rev Microbiol. 2016 Feb;14(2):93-105 - PubMed
  129. Cochrane Database Syst Rev. 2013 Jun 06;(6):CD007878 - PubMed
  130. Am J Kidney Dis. 2010 Jun;55(6):1060-8 - PubMed
  131. Nephrol Dial Transplant. 2012 Sep;27(9):3575-81 - PubMed
  132. J Am Soc Nephrol. 2002 Aug;13(8):2133-9 - PubMed
  133. Nephrol Dial Transplant. 2004 Jun;19(6):1546-51 - PubMed
  134. Antimicrob Agents Chemother. 2010 Jun;54(6):2707-11 - PubMed
  135. Microb Cell Fact. 2015 Apr 09;14:48 - PubMed
  136. Front Microbiol. 2015 Jul 10;6:699 - PubMed
  137. Environ Microbiol. 2011 Sep;13(9):2416-34 - PubMed
  138. BMC Nephrol. 2012 Nov 02;13:146 - PubMed
  139. Gut Microbes. 2012 Sep-Oct;3(5):449-54 - PubMed
  140. Crit Care Med. 2010 Nov;38(11):2095-102 - PubMed
  141. J Appl Microbiol. 2005;98(1):238-44 - PubMed
  142. Antimicrob Agents Chemother. 2014 Nov;58(11):6385-97 - PubMed
  143. ISME J. 2014 Jun;8(6):1275-88 - PubMed
  144. Appl Environ Microbiol. 2014 Nov;80(22):7028-35 - PubMed
  145. Gut Pathog. 2013 May 13;5(1):11 - PubMed
  146. J Med Microbiol. 2014 Nov;63(Pt 11):1509-16 - PubMed
  147. Antimicrob Agents Chemother. 2007 Dec;51(12):4255-60 - PubMed
  148. JAMA. 2008 Aug 20;300(7):805-13 - PubMed
  149. Antimicrob Agents Chemother. 2004 Jul;48(7):2633-6 - PubMed
  150. Crit Care Med. 2011 Apr;39(4):613-20 - PubMed
  151. Cell Microbiol. 2014 Dec;16(12):1836-53 - PubMed
  152. Biofouling. 2014;30(10):1175-82 - PubMed
  153. Nature. 2010 May 20;465(7296):346-9 - PubMed
  154. Int J Hyg Environ Health. 2011 Nov;214(6):417-23 - PubMed
  155. Crit Care Med. 2011 Feb;39(2):245-51 - PubMed
  156. J Biomed Biotechnol. 2008;2008:357964 - PubMed
  157. Curr Microbiol. 2014 May;68(5):635-41 - PubMed

Publication Types